Orbimed Advisors - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q1 2017$2,382,000
-11.2%
300,0000.0%0.03%
-20.6%
Q4 2016$2,682,000300,0000.03%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders